FOLFOX is a combination of the drugs folinic acid, 5-fluorouracil and oxaliplatin. A total of 173 patients were included in the trial, which was conducted at about 30
According to the companies, the deal has the potential to result in new patient friendly cancer treatments that could be a significant step towards personalized medicine. As part
WuXi MedImmune Biopharmaceutical is a joint venture (JV) formed in September 2012 by AstraZeneca’s global biologics research and development arm MedImmune, and WuXi AppTec. The JV was created
The validation of MAA confirms that the submission is complete and signifies the start of the review process by the EMA’s Committee for Medicinal Products for Human Use
In May last year, the company submitted a NDA to the FDA pursuant to Section 505(b)(2) of the Food, Drug & Cosmetic Act, as amended, for approval of
The meningitis B vaccine will be introduced as part of the National Health Service’s (NHS) NHS immunization program, which is scheduled to be initiated in September. UK Health
Lenvima is an orally administered molecular targeted agent which inhibits the activities of several different molecules such as VEGFR, FGFR, RET, KIT and PDGFR. Mainly, the agent simultaneously
Gadovist is the first high concentration/high relaxivity gadolinium-based contrast agent to be approved in Japan. In Japan, there are more than 1.6 million MRI procedures conducted each year
The open label, multi-dose, safety and pharmacokinetic (PK) study is expected to enroll around 46 subjects with schizophrenia or schizoaffective disorder. Relday has been designed to offer potentially
Zafatek (trelagliptin succinate) controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.